Blood pressure circadian rhythm alterations in alpha-synucleinopathies.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
May 2019
Historique:
received: 14 12 2018
accepted: 14 02 2019
revised: 09 02 2019
pubmed: 21 2 2019
medline: 14 8 2019
entrez: 21 2 2019
Statut: ppublish

Résumé

We sought to analyze the blood pressure (BP) circadian rhythm in Parkinson's disease (PD), multiple system atrophy (MSA), and pure autonomic failure (PAF) and to evaluate the effect of vasoactive and dopaminergic medications on BP fluctuations during activities of daily living. We analyzed data from patients with PD (n = 72), MSA (n = 18), and PAF (n = 17) evaluated with 24-h ambulatory BP monitoring (ABPM) at our Center between 1996 and 2015. Comparisons between groups were performed according to (a) clinical diagnosis and (b) pharmacological treatment. ABPM parameters included 24-h BP variability, BP load, nocturnal dipping, and awakening hypotension. The average BP was 121 ± 14/72 ± 8 mmHg during daytime and 133 ± 20/76 ± 13 mmHg during nighttime (p < 0.01), with BP load of 24 ± 22/15 ± 16% (daytime) vs. 61 ± 36/52 ± 36% (nighttime) (p < 0.01). In-office BP measurements were consistent with OH in 95 patients (89%) and SH in 63 (59%). ABPM demonstrated increased BP variability in 67 patients (63%), awakening hypotension in 63 (59%), "reverse dipping" in 85 (79.4%), "reduced dipping" in 13 (12.1%), and "normal dipping" in 9 (8.4%). No differences were observed between PD, MSA, and PAF, but a sub-analysis of PD patients revealed two distinct patterns of BP alterations. No significant differences were observed in relation to the use of vasoactive or dopaminergic medications. Regardless of the neurological diagnosis and pharmacological treatment, patients with alpha-synucleinopathies showed a BP circadian rhythm characterized by increased BP variability, reverse dipping, increased BP load, and awakening hypotension.

Identifiants

pubmed: 30783749
doi: 10.1007/s00415-019-09244-w
pii: 10.1007/s00415-019-09244-w
doi:

Substances chimiques

Antihypertensive Agents 0
Dopamine Agents 0
Vasoconstrictor Agents 0

Types de publication

Journal Article

Langues

eng

Pagination

1141-1152

Références

Lancet. 2000 Feb 26;355(9205):725-6
pubmed: 10703810
J Neurol Neurosurg Psychiatry. 2003 Sep;74 Suppl 3:iii31-41
pubmed: 12933912
Mov Disord. 2003 Sep;18 Suppl 6:S21-7
pubmed: 14502652
Lancet Neurol. 2006 Jun;5(6):525-35
pubmed: 16713924
Eur J Neurol. 2006 Sep;13(9):930-6
pubmed: 16930356
Eur J Intern Med. 2006 Oct;17(6):417-20
pubmed: 16962949
Am J Hypertens. 2006 Oct;19(10):1049-54
pubmed: 17027826
J Hum Hypertens. 2007 May;21(5):381-6
pubmed: 17301823
Clin Auton Res. 1991 Dec;1(4):309-15
pubmed: 1822265
Neurology. 2008 Aug 26;71(9):670-6
pubmed: 18725592
Hypertension. 2009 Nov;54(5):1057-61
pubmed: 19738158
Radiology. 2010 May;255(2):563-9
pubmed: 20413765
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Diabetes Metab Res Rev. 2011 Oct;27(7):639-53
pubmed: 21695768
J Neurol Sci. 2011 Nov 15;310(1-2):133-8
pubmed: 21849175
Parkinsonism Relat Disord. 2012 Jan;18(1):17-20
pubmed: 21868276
Clin Auton Res. 2012 Apr;22(2):79-90
pubmed: 22045363
Hypertension. 2012 Aug;60(2):369-77
pubmed: 22753222
Curr Opin Nephrol Hypertens. 2012 Sep;21(5):481-5
pubmed: 22801444
Eur J Neurol. 2013 Feb;20(2):231-5
pubmed: 22834919
Hypertension. 2013 Mar;61(3):701-6
pubmed: 23266540
J Clin Hypertens (Greenwich). 2013 Mar;15(3):147-53
pubmed: 23458585
Chronobiol Int. 2013 Jul;30(6):811-7
pubmed: 23742007
Eur Heart J. 2013 Jul;34(28):2159-219
pubmed: 23771844
Clin Auton Res. 2014 Aug;24(4):189-92
pubmed: 24710680
J Neurol. 2014 Jul;261(7):1291-9
pubmed: 24737171
Parkinsonism Relat Disord. 2014 Aug;20(8):815-8
pubmed: 24819390
J Hypertens. 2014 Jul;32(7):1359-66
pubmed: 24886823
Clin Auton Res. 2015 Jun;25(3):133-40
pubmed: 25791260
Hypertension. 2015 Dec;66(6):1168-75
pubmed: 26459422
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
Can J Neurol Sci. 2016 May;43(3):390-7
pubmed: 26853109
Parkinsonism Relat Disord. 2016 Dec;33:65-71
pubmed: 27641792
Eur J Neurol. 2017 Jan;24(1):90-97
pubmed: 27718292
J Neurol. 2017 Aug;264(8):1567-1582
pubmed: 28050656
Ann Neurol. 2017 Feb;81(2):287-297
pubmed: 28093795
Mov Disord Clin Pract. 2017 Jan;4(1):141-144
pubmed: 28164144
Neurology. 2017 Mar 21;88(12):1129-1136
pubmed: 28202694
Sci Rep. 2017 Mar 07;7:43965
pubmed: 28266630
Brain. 2017 Jul 1;140(7):1959-1976
pubmed: 28549077
Pulm Circ. 2017 Apr-Jun;7(2):486-493
pubmed: 28597780
Clin Auton Res. 2018 Apr;28(2):245-246
pubmed: 29080922
Mov Disord. 2018 Mar;33(3):391-397
pubmed: 29278286
Mov Disord. 2018 Mar;33(3):349-358
pubmed: 29297596
Neurology. 2018 Jun 5;90(23):1045-1046
pubmed: 29728530
Clin Auton Res. 2018 Aug;28(4):355-362
pubmed: 29766366
Parkinsonism Relat Disord. 2018 Nov;56:82-87
pubmed: 30057156
Acta Neuropathol. 1997 Aug;94(2):192-6
pubmed: 9255396
Prog Brain Res. 1977;47:331-6
pubmed: 928753
Neurology. 1997 Nov;49(5):1284-8
pubmed: 9371909
J Hypertens. 1998 Oct;16(10):1433-41
pubmed: 9814613
J Am Soc Nephrol. 1999 Jan;10(1):35-42
pubmed: 9890307

Auteurs

Fabrizio Vallelonga (F)

Autonomic Unit and Hypertension Unit, Department of Medical Sciences, University of Turin, via Genova 3, 10126, Turin, Italy. vallelonga.fabrizio@gmail.com.

Cristina Di Stefano (C)

Autonomic Unit and Hypertension Unit, Department of Medical Sciences, University of Turin, via Genova 3, 10126, Turin, Italy.

Aristide Merola (A)

Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH, USA.

Alberto Romagnolo (A)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, via Cherasco 15, 10124, Turin, Italy.

Gabriele Sobrero (G)

Autonomic Unit and Hypertension Unit, Department of Medical Sciences, University of Turin, via Genova 3, 10126, Turin, Italy.

Valeria Milazzo (V)

Autonomic Unit and Hypertension Unit, Department of Medical Sciences, University of Turin, via Genova 3, 10126, Turin, Italy.

Alessio Burrello (A)

Department of Electronics and Telecommunications, Polytechnic University of Turin, Turin, Italy.

Jacopo Burrello (J)

Autonomic Unit and Hypertension Unit, Department of Medical Sciences, University of Turin, via Genova 3, 10126, Turin, Italy.

Maurizio Zibetti (M)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, via Cherasco 15, 10124, Turin, Italy.

Franco Veglio (F)

Autonomic Unit and Hypertension Unit, Department of Medical Sciences, University of Turin, via Genova 3, 10126, Turin, Italy.

Simona Maule (S)

Autonomic Unit and Hypertension Unit, Department of Medical Sciences, University of Turin, via Genova 3, 10126, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH